As biotechnology stocks have fallen, visions of a bubble bursting have risen. After all, as The Wall Street Journal reminds us, “What goes up must come down….” Then there are those sky-high valuations and all those IPOs. Clearly, a disaster was waiting to happen, and now investors (again, per the WSJ) are “…learning the... »
